Falcão de Arruda Ira S, de Aguilar-Nascimento José E
Department of Surgery, Federal University of Mato Grosso Medical Sciences School, Julio Muller University Hospital, Cuiabá MT 78045-200, Brazil.
Clin Sci (Lond). 2004 Mar;106(3):287-92. doi: 10.1042/CS20030251.
Brain injury patients have higher energy and protein expenditures and are prone to infections. The aim of the present study was to evaluate the results of early enteral feeding with glutamine and probiotics in brain injury patients. Twenty-three brain injury patients (Glasgow score between 5-12 and therapeutic intervention scoring system>20) were studied. Three patients were excluded to leave 20 remaining patients. Patients were randomized to receive either an early enteral diet (control group, n=10) or the same formula with glutamine and probiotics added (study group, n=10) for a minimum of 5 days (range, 5-14 days). The diets were isocaloric and isonitrogenous [35 kcal.kg(-1).day(-1) (where 1 kcal approximately 4.184 kJ) and 1.5 g of protein.kg(-1).day(-1)]. Main outcome measures were the incidence of infection, the length of stay in the intensive care unit and the number of days requiring mechanical ventilation. The two groups were homogeneous in gender, age, nutritional status and severity of trauma. There was no mortality during the study period. The infection rate was higher in controls (100%) when compared with the study group (50%; P=0.03) and the median (range) number of infections per patient was significantly greater (P<0.01) in the control group [3 (1-5)] compared with the study group [1 (0-3)]. Both the critical care unit stay [22 (7-57) compared with 10 (5-20) days; P<0.01; median (range)] and days of mechanical ventilation [14 (3-53) compared with 7 (1-15) days; P=0.04; median (range)] were higher in the patients in the control group than in the study group. We conclude that the enteral formula containing glutamine and probiotics decreased the infection rate and shortened the stay in the intensive care unit of brain injury patients.
脑损伤患者能量和蛋白质消耗更高,且容易发生感染。本研究旨在评估早期肠内营养补充谷氨酰胺和益生菌对脑损伤患者的效果。研究了23例脑损伤患者(格拉斯哥评分在5 - 12分之间且治疗干预评分系统>20)。排除3例患者后,剩余20例患者。患者被随机分为两组,一组接受早期肠内饮食(对照组,n = 10),另一组接受添加了谷氨酰胺和益生菌的相同配方饮食(研究组,n = 10),持续至少5天(范围为5 - 14天)。饮食的热量和氮含量相同[35千卡·千克⁻¹·天⁻¹(1千卡约等于4.184千焦)和1.5克蛋白质·千克⁻¹·天⁻¹]。主要观察指标为感染发生率、重症监护病房住院时间以及需要机械通气的天数。两组在性别、年龄、营养状况和创伤严重程度方面具有同质性。研究期间无死亡病例。与研究组(50%;P = 0.03)相比,对照组的感染率更高(100%),且对照组每位患者的感染中位数(范围)[3(1 - 5)]显著高于研究组[1(0 - 3)](P < 0.01)。对照组患者的重症监护病房住院时间[22(7 - 57)天与10(5 - 20)天;P < 0.01;中位数(范围)]和机械通气天数[14(3 - 53)天与7(1 - 15)天;P = 0.04;中位数(范围)]均高于研究组。我们得出结论,含有谷氨酰胺和益生菌的肠内配方可降低脑损伤患者的感染率,并缩短其在重症监护病房的住院时间。